Atlas Trials

Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell Carcinoma

Clinical trial NCT05760053 · UNKNOWN

Trial details

NCT number
NCT05760053
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
ToripalimabFirst-line Treatment
Start date
2023-02-18
Primary completion
2025-02-18
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.